Exhibit 99.1

                                                            Investor Inquiries:
                                                            Greg Thompson
                                                            440-329-6111

NEWS RELEASE


DIFFICULTIES IN NEW SYSTEMS  IMPLEMENTATION CAUSES INVACARE CORPORATION TO LOWER
FOURTH QUARTER EARNINGS GUIDANCE

ELYRIA,  Ohio - (December  14, 2005) - Invacare  Corporation  (NYSE:  IVC) today
announced  anticipated  fourth  quarter sales and earnings  performance  will be
below its  expectations  due to  extensive  but  temporary  disruption  of order
processing capability and inefficiencies  resulting from the implementation of a
new $20 million  enterprise  resource  planning  system (ERP) for the  Company's
North American home care businesses.

These issues have  resulted in lost revenues due to  difficulties  in processing
orders and the  inability to ship  products to customers  within  required  lead
times.  The   implementation  is  also  resulting  in  additional   overtime  in
manufacturing,  distribution  centers,  and customer  service,  along with added
costs to expedite  product to customers  and is resulting in processing a higher
than normal  level of returns.  The Company  continues  to work  through the ERP
implementation issues and expects these start-up issues to be generally resolved
by December 31;  however,  these issues are expected to result in an anticipated
revenue shortfall of approximately $30 million for the fourth quarter.

In light of these issues,  Invacare is lowering  guidance for earnings per share
for the fourth  quarter of 2005 from the  previous  range of $0.55 to $0.70 to a
new range of $0.30 to $0.40.  The earnings per share  guidance  does not include
the  impact of the  previously  communicated  $4 to $5  million  fourth  quarter
restructuring  charge on a pre-tax  basis or $0.08 to $0.10 per share after tax.
Net sales for the quarter will likely  range from $370 million to $380  million,
or 3% to 6% lower than the fourth  quarter of last year.  Prior guidance for the
quarter  was  for  an  increase  of 2% to 4%.  Excluding  foreign  currency  and
acquisitions, the net sales decrease is estimated to be between 5% and 8%, while
the previous net sales guidance was for an increase of between zero and 2%.

For the full year,  the Company  believes that it will have a net sales increase
of between 9% and 10% and  earnings per share of between  $1.65 and $1.75.  This
compares to prior  guidance  of a net sales  increase of between 11% and 12% and
earnings per share of between $1.90 and $2.05.  The earnings per share  guidance
does not include the impact of the previously  communicated $6.8 million to $7.8
million  restructuring  charge  on a pre-tax  basis  for the  third  and  fourth
quarters or $0.14 to $0.16 per share after tax.  Excluding  foreign currency and
acquisitions, the net sales change is estimated to be between zero and a decline
of 1%, while the  previous net sales  guidance was for an increase of between 1%
and 2%.  Free cash flow for the year is now  expected  to be between $35 million
and $45 million.  This  compares to prior free cash flow guidance of $55 million
to $65 million.

The new ERP system is now approaching  pre-implementation  performance levels in
most  respects,  including  the  processing  of orders,  product  shipments  and
customer   invoicing.   Backlogs   together  with   invoicing   and   additional
documentation  errors  encountered  in the  first  eight  weeks  after  the  ERP
implementation is expected to be resolved by year end.

Commenting on the Company's new ERP system,  A. Malachi Mixon, III, chairman and
chief executive officer,  stated, "Our order intake capability has substantially
recovered  and,  with  the  addition  of  added  processing  capacity  and a few
remaining application refinements,  we are confident we will be in a position to
offer our customers significantly enhanced service and support early next year."

Mixon concluded,  "Although we are  disappointed  with the likely fourth quarter
results and the  adjustment  to previous  guidance,  the  Company  continues  to
execute on its previously  announced  plans to reduce costs and reconfirms  that
these cost reduction  initiatives should result in annualized pre-tax savings of
at least $25 million as Invacare  enters 2006. The fourth quarter impacts of the
ERP are  disappointing,  but this is a  one-time  event and does not  change our
outlook for 2006 and beyond of significantly improved profitability arising from
our cost reduction actions."



Invacare  Corporation  (NYSE:IVC),  headquartered in Elyria, Ohio, is the global
leader in the manufacture and distribution of innovative home and long-term care
medical  products that promote recovery and active  lifestyles.  The Company has
6,200  associates and markets its products in 80 countries around the world. For
more information about the Company and its products, visit Invacare's website at
www.invacare.com.

This press release contains forward-looking statements within the meaning of the
"Safe Harbor"  provisions  of the Private  Securities  Litigation  Reform Act of
1995. Terms such as "will," "should," "plan,"  "intend,"  "expect,"  "continue,"
"forecast", "believe," "anticipate" and "seek," as well as similar comments, are
forward-looking  in nature.  Actual results and events may differ  significantly
from those expressed or anticipated as a result of risks and uncertainties which
include, but are not limited to, the following:  pricing pressures,  the success
of the Company's ongoing efforts to reduce costs, increasing raw material costs,
the  consolidations  of  health  care  customers  and  competitors,   government
reimbursement  issues  (including  those that affect the sales of and margins on
product,  along with the viability of  customers)  both at the federal and state
level,  the  successful  implementation  of the  Company's  enterprise  resource
planning  system,  the ability to design,  manufacture,  distribute  and achieve
market acceptance of new products with higher functionality and lower costs, the
effect of offering customers competitive financing terms,  Invacare's ability to
successfully identify,  acquire and integrate strategic acquisition  candidates,
the difficulties in managing and operating  businesses in many different foreign
jurisdictions (including the recent Domus acquisition), the timely completion of
facility   consolidations,   the  vagaries  of  any   litigation  or  regulatory
investigations  that  the  Company  may be or  become  involved  in at any  time
(including  the   previously-disclosed   litigation   with   Respironics),   the
difficulties  in acquiring and maintaining a proprietary  intellectual  property
ownership position, the overall economic,  market and industry growth conditions
(including   the  impact  that  acts  of  terrorism  may  have  on  such  growth
conditions),  foreign  currency and interest rate risks,  Invacare's  ability to
improve  financing  terms  and  reduce  working  capital,  as well as the  risks
described  from time to time in Invacare's  reports as filed with the Securities
and Exchange  Commission.  We undertake no  obligation to review or update these
forward-looking statements or other information contained herein.


                                       ###